The serum concentration of Budesonide can be decreased when it is combined with Dabrafenib. Budesonide may increase the fluid retaining activities of Oxymetholone. Budesonide may increase the fluid retaining activities of Nandrolone decanoate. Budesonide may increase the fluid retaining activities of GLPG-0492. The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Budesonide. The risk or severity of adverse effects can be increased when Isoxicam is combined with Budesonide. The risk or severity of adverse effects can be increased when Apremilast is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Atazanavir. The risk or severity of adverse effects can be increased when Floctafenine is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Fusidic Acid. The risk or severity of adverse effects can be increased when Naproxen is combined with Budesonide. Budesonide may increase the hypokalemic activities of Hydroflumethiazide. The risk or severity of adverse effects can be increased when Budesonide is combined with Edrophonium. The metabolism of Budesonide can be increased when combined with Fosphenytoin. The bioavailability of Budesonide can be decreased when combined with Calcium Carbonate. Budesonide may increase the hypokalemic activities of Methyclothiazide. The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Bortezomib. The serum concentration of Budesonide can be increased when it is combined with Luliconazole. The risk or severity of adverse effects can be increased when Celecoxib is combined with Budesonide. The risk or severity of adverse effects can be increased when Salicylic acid is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Posaconazole. The serum concentration of Budesonide can be increased when it is combined with Conjugated estrogens. The serum concentration of Budesonide can be increased when it is combined with Equol. The serum concentration of Budesonide can be increased when it is combined with Ketoconazole. The bioavailability of Budesonide can be decreased when combined with Sodium bicarbonate. The serum concentration of Budesonide can be increased when it is combined with Conivaptan. The bioavailability of Budesonide can be decreased when combined with Magnesium Hydroxide. The risk or severity of adverse effects can be increased when Carprofen is combined with Budesonide. Atracurium besylate may increase the adverse neuromuscular activities of Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with Sparfloxacin. The serum concentration of Budesonide can be increased when it is combined with Clarithromycin. The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Budesonide. Budesonide may increase the hypokalemic activities of Piretanide. The risk or severity of adverse effects can be increased when Bromfenac is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Simeprevir. The bioavailability of Budesonide can be decreased when combined with Aluminum hydroxide. The risk or severity of adverse effects can be increased when Nafamostat is combined with Budesonide. The risk or severity of adverse effects can be increased when Lisofylline is combined with Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with G17DT. The risk or severity of adverse effects can be increased when Aceclofenac is combined with Budesonide. The risk or severity of adverse effects can be increased when Denosumab is combined with Budesonide. The risk or severity of adverse effects can be increased when Nepafenac is combined with Budesonide. Budesonide may increase the hypokalemic activities of Metolazone. The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Fosamprenavir. Budesonide may increase the hypokalemic activities of Cyclopenthiazide. Budesonide may increase the fluid retaining activities of Fluoxymesterone. The risk or severity of adverse effects can be increased when Budesonide is combined with Nalidixic Acid. The serum concentration of Budesonide can be increased when it is combined with Promestriene. The serum concentration of Budesonide can be increased when it is combined with Hexestrol. The risk or severity of adverse effects can be increased when Tinoridine is combined with Budesonide. The risk or severity of adverse effects can be increased when Indoprofen is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Methallenestril. The risk or severity of adverse effects can be increased when Budesonide is combined with Temafloxacin. The bioavailability of Budesonide can be decreased when combined with Tromethamine. The risk or severity of adverse effects can be increased when Olopatadine is combined with Budesonide. Budesonide may increase the fluid retaining activities of Stanozolol. The risk or severity of adverse effects can be increased when Etofenamate is combined with Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with Pazufloxacin. The risk or severity of adverse effects can be increased when Masoprocol is combined with Budesonide. The risk or severity of adverse effects can be increased when Fenoprofen is combined with Budesonide. The risk or severity of adverse effects can be increased when Anisodamine is combined with Budesonide. The risk or severity of adverse effects can be increased when Serrapeptase is combined with Budesonide. The metabolism of Budesonide can be increased when combined with Carbamazepine. The serum concentration of Isoniazid can be decreased when it is combined with Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated). The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Nefazodone. Mivacurium may increase the adverse neuromuscular activities of Budesonide. Budesonide may increase the fluid retaining activities of Oxandrolone. Budesonide may decrease the antineoplastic activities of Aldesleukin. The serum concentration of Budesonide can be increased when it is combined with Crizotinib. The risk or severity of adverse effects can be increased when Nimesulide is combined with Budesonide. The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Budesonide. The risk or severity of adverse effects can be increased when Fenbufen is combined with Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with Pefloxacin. The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with Minaprine. The risk or severity of adverse effects can be increased when Propacetamol is combined with Budesonide. The risk or severity of adverse effects can be increased when Salsalate is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Ticlopidine. The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Clotrimazole. The risk or severity of adverse effects can be increased when Budesonide is combined with Grepafloxacin. The risk or severity of adverse effects can be increased when Ketoprofen is combined with Budesonide. Indacaterol may increase the hypokalemic activities of Budesonide. The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Diethylstilbestrol. The serum concentration of Budesonide can be increased when it is combined with Verapamil. The serum concentration of Budesonide can be increased when it is combined with Lovastatin. The risk or severity of adverse effects can be increased when Tenoxicam is combined with Budesonide. The risk or severity of adverse effects can be increased when Adapalene is combined with Budesonide. The risk or severity of adverse effects can be increased when Alclofenac is combined with Budesonide. The risk or severity of adverse effects can be increased when Metamizole is combined with Budesonide. The risk or severity of adverse effects can be increased when Ferulic acid is combined with Budesonide. The risk or severity of adverse effects can be increased when Epirizole is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Fosaprepitant. The serum concentration of Budesonide can be increased when it is combined with Imatinib. The risk or severity of adverse effects can be increased when Parthenolide is combined with Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with Echothiophate. Budesonide may increase the hypokalemic activities of Indapamide. The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Budesonide. The risk or severity of adverse effects can be increased when Acemetacin is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Aprepitant. Budesonide may increase the fluid retaining activities of Testosterone. The risk or severity of adverse effects can be increased when Teriflunomide is combined with Budesonide. The risk or severity of adverse effects can be increased when Seratrodast is combined with Budesonide. The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Budesonide. The risk or severity of adverse effects can be increased when Budesonide is combined with Malathion. The risk or severity of adverse effects can be increased when Budesonide is combined with Tacrine. The risk or severity of adverse effects can be increased when Balsalazide is combined with Budesonide. The risk or severity of adverse effects can be increased when Mesalazine is combined with Budesonide. The risk or severity of adverse effects can be increased when Curcumin is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Telithromycin. The metabolism of Budesonide can be increased when combined with Primidone. The serum concentration of Budesonide can be increased when it is combined with Clemastine. The serum concentration of Budesonide can be increased when it is combined with Erythromycin. The risk or severity of adverse effects can be increased when Budesonide is combined with Demecarium. The risk or severity of adverse effects can be increased when Budesonide is combined with Neostigmine. The bioavailability of Budesonide can be decreased when combined with Magaldrate. The serum concentration of Budesonide can be increased when it is combined with Synthetic Conjugated Estrogens, B. The risk or severity of adverse effects can be increased when Higenamine is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Estrone. Rapacuronium may increase the adverse neuromuscular activities of Budesonide. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Budesonide. The serum concentration of Budesonide can be increased when it is combined with Voriconazole. The risk or severity of adverse effects can be increased when Budesonide is combined with Rosoxacin. The risk or severity of adverse effects can be increased when Budesonide is combined with Norfloxacin. The metabolism of Budesonide can be increased when combined with Phenobarbital.